Professional Documents
Culture Documents
disease
Login: Register
Home
Quick Search
Browse
All fields Journal/ book title
Search
My Settings
Author Volume
Alerts
Help
Issue
Page
Advanced Search
Font Size:
Abstract
Article Figures/Tables References
Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease
Peng Qua, Jennifer Robertsa, Yuan Lib, Marjorie Albrechta, Oscar W. Cummingsa, John N. Eblea, Hong Dub and Cong Yana,
,
aDepartment
of Pathology and Laboratory Medicine, The Center for Immunobiology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN
Related Articles in ScienceDirect Association of Chronic Obstructive Pulmonary Disease an... The Annals of Thoracic Surgery M1020 The Impact of Gastroesophageal Reflux Symptoms On... Gastroenterology Lung squamous cell carcinoma presenting with brain meta... Lung Cancer A study of the association between squamous cell carcin... Lung Cancer
46202, USA
bDivision
of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA
Received 17 March 2008; revised 14 May 2008; accepted 29 May 2008. Available online 9 July 2008.
Summary
Smoking causes lung cancer and chronic obstructive pulmonary disease (COPD) that impose severe health problem to humans. Both diseases are related to each other and can be induced by chronic inflammation in the lung. To identify the molecular mechanism for lung cancer formation, a CCSP-rtTA/(teto)7Stat3C bitransgenic model was generated recently. In this model, persistent activation of the Stat3 signaling pathway induced pulmonary inflammation and adenocarcinoma formation in the lung. A group of Stat3 downstream genes were identified by Affymetrix GeneChip microarray analysis that can be used as biomarkers for lung cancer diagnosis and prognosis. To determine which human lung cancers are related to the Stat3 pathway, multiple Stat3 downstream genes were screened in human lung cancers (adenocarcinomas and squamous cell carcinomas) and lung tissue with COPD. In both cancer and COPD, the Stat3 gene was up-regulated. A panel of Stat3-up-regulated downstream genes in mice was up-regulated in human adenocarcinomas, but not in human squamous cell carcinomas. This panel of genes was also modestly up-regulated in lung tissue with COPD from patients with a history of smoking and not up-regulated in those without histories of smoking. Several Stat3-
In vivo cell kinetic measurements in human oesophageal ... European Journal of Cancer View More Related Articles
ScienceDirect - Lung Cancer : Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease down-regulated downstream genes also showed differential expression patterns in carcinoma and COPD. These studies support a concept that Stat3 is a potent oncogenic molecule that plays a role in formation of lung adenocarcinomas in both mice and humans. The carcinogenesis of adenocarcinoma and squamous cell carcinoma is mediated by different molecular mechanisms and pathways in vivo. Stat3 and its downstream genes can serve as biomarkers for lung adenocarcinoma and COPD diagnosis and prognosis in mice and humans.
The research collaboration tool No user rating No user tags yet This article has not yet been bookmarked No comments on this article yet Not yet shared with any groups
Keywords: Stat3; Adenocarcinoma; Squamous cell carcinoma; COPD; Biomarkers; Real-Time qRT-PCR
Article Outline
1. Introduction 2. Materials and methods 2.1. Human tissue 2.2. Isolation of total RNAs and Real-Time PCR 2.2.1. Human Real-Time PCR primers 3. Results 3.1. Pre-screening of human samples 3.2. Up-regulation of the Stat3 gene 3.3. Changes of the Stat3 up-regulated genes in human adenocarcinomas 3.4. Changes of the Stat3-up-regulated genes in lung tissue with COPD 3.5. Changes of the Stat3-down-regulated genes in the lung with COPD and in adenocarcinoma and squamous cell carcinoma 4. Discussion Conflict of interest Acknowledgements References
Corresponding author. Tel.: +1 317 278 6005; fax: +1 317 278 7030.
Note to users: The section "Articles in Press" contains peer reviewed accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated published journal issue. The date it was first made available online will be carried over. Please be aware that although "Articles in Press" do not have all bibliographic details available yet, they can already be cited using the year of online publication and the DOI as follows: Author(s), Article Title, Journal (Year), DOI. Please consult the journal's reference style for the exact appearance of these elements, abbreviation of journal names and the use of punctuation. There are three types of "Articles in Press":
G
Accepted manuscripts: these are articles that have been peer reviewed and accepted for publication by the Editorial Board. The articles have not yet been copy edited and/or formatted in the journal house style. Uncorrected proofs: these are copy edited and formatted articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Corrected proofs: these are articles containing the authors' corrections and may, or may not yet have specific issue and page numbers assigned.
ScienceDirect - Lung Cancer : Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease
Home
Browse
Search
My Settings
Alerts
Help
About ScienceDirect | Contact Us | Information for Advertisers | Terms & Conditions | Privacy Policy Copyright 2009 Elsevier B.V. All rights reserved. ScienceDirect is a registered trademark of Elsevier B. V.